Multiplexed imaging of tumor immune microenvironmental markers in locally advanced or metastatic non‐small‐cell lung cancer characterizes the features of response to PD‐1 blockade plus chemotherapy.

MLA

Wu, Fengying, et al. “Multiplexed Imaging of Tumor Immune Microenvironmental Markers in Locally Advanced or Metastatic Non‐small‐cell Lung Cancer Characterizes the Features of Response to PD‐1 Blockade plus Chemotherapy.” Cancer Communications, vol. 42, no. 12, Dec. 2022, pp. 1331–46. EBSCOhost, https://doi.org/10.1002/cac2.12383.

APA

Wu, F., Jiang, T., Chen, G., Huang, Y., Zhou, J., Lin, L., Feng, J., Wang, Z., Shu, Y., Shi, J., Hu, Y., Wang, Q., Cheng, Y., Chen, J., Lin, X., Wang, Y., Huang, J., Cui, J., Cao, L., & Liu, Y. (2022). Multiplexed imaging of tumor immune microenvironmental markers in locally advanced or metastatic non‐small‐cell lung cancer characterizes the features of response to PD‐1 blockade plus chemotherapy. Cancer Communications, 42(12), 1331–1346. https://doi.org/10.1002/cac2.12383

Chicago

Wu, Fengying, Tao Jiang, Gongyan Chen, Yunchao Huang, Jianying Zhou, Lizhu Lin, Jifeng Feng, et al. 2022. “Multiplexed Imaging of Tumor Immune Microenvironmental Markers in Locally Advanced or Metastatic Non‐small‐cell Lung Cancer Characterizes the Features of Response to PD‐1 Blockade plus Chemotherapy.” Cancer Communications 42 (12): 1331–46. doi:10.1002/cac2.12383.